Introduction
The clinical manifestation of acute coronary syndromes, which include both acute myocardial infarction and unstable angina, may largely depend on the presence and severity of functional factors that transiently and acutely interfere with coronary blood flow, together with an extremely variable degree of coronary atherosclerosis' 11 . In the past, several studies have described an increase in C-reactive protein after myocardial infarction, which may reflect an important inflammatory component in this clinical situation' 2 " 41 . The syndrome of unstable angina occurs most commonly in the setting of atherosclerotic coronary artery disease and frequently progresses to acute myocardial infarction. Coronary thrombosis and vasospasm are known to be implicated in the pathogenesis of myocardial infarction 15 -61 , but the underlying causes of unstable angina are not clear. Although the cell biology of atherosclerosis is not completely defined, inflammation may play a part in unstable angina, as suggested by histological studies of coronary plaques' 71 , the release of thromboxanes and leukotrienes' 8 ' 9 ', the increased expression of leukocyte receptors in the presence of activated circulating leukocytes that may include coronary vasoconstriction, favour thrombotic processes, and activate platelets 1 ' 01 . Currently, there is a reduction in the time between the onset of chest pain and hospital admission' 11! . As more patients with acute ischaemic heart disease will be hospitalized in the future, predicting the prognosis of these patients very early and managing them accordingly will be crucial. Recently, two studies reported on the possible prognostic value of circulating active-phase C-reactive protein, which may reflect the inflammatory pathogenesis in patients suffering unstable angina' 12 ' 131 . To characterize the presence of 'active' atherosclerotic lesions in patients admitted with suspected acute ischaemic heart disease, we measured the value of C-reactive protein at the time of hospital admission and compared it with the final diagnosis of these patients.
Methods

Patients
The study population comprised 110 of 201 consecutive patients admitted to the emergency centre of the Geneva Hospital with chest pain between January and June 1994, and in whom myocardial infarction was suspected according to the clinical and electrocardiographic criteria of the Imminent Myocardial Infarction Rotterdam Study'
141 . There were 90 men and 20 women, with a mean ( ± SD) age of 65 ± 11 years. The criteria for enrollment were the following: chest pain at rest, with at least two episodes in the previous 48 h, or one episode lasting more than 20 min; ST-segment changes on ECG diagnostic of myocardial ischaemia during anginal attacks; no elevation of serum creatine kinase and creatine kinase-MB levels at the time of hospital admission. The criteria for exclusion were an interval of more than 24 h since the last ischaemic episode before hospitalization (47 patients), intercurrent inflammatory or neoplastic conditions likely to be associated with an acute-phase response (29 patients), acute myocardial infarction within the previous month (eight patients), valvular heart disease (four patients), and chronic dissecting aortic aneurysm (three patients). All patients were studied prospectively without knowledge of C-reactive protein serum levels. Ninety-eight patients (89%) stayed in the intensive care unit for 2-4 ± 2-4 days after admission. All patients received various combinations of intravenous or oral nitrates, beta-blockers, aspirin, heparin and calcium antagonists. Nineteen patients (17%) were treated with thrombolysis (rTPA) started in the emergency room. Coronary angiography was performed within 2-5 ± 2-2 days of admission in 103 patients (94%), 63 patients (57%) underwent percutaneous transluminal coronary angioplasty, and 24 (22%) coronary artery bypass grafting.
These 110 patients were divided into two groups based on their final diagnosis: Group 1 comprised 61 patients with a final diagnosis of unstable angina (51 men and 10 women; with a mean ( ± SD) age of 65 ± 11 years), and Group 2, 49 patients with a final diagnosis of acute myocardial infarction (39 men and 10 women; with a mean ( ± SD) age of 66 ± 12 years). The diagnosis of acute myocardial infarction was made by a physician independent of the study, according to the electrocardiographic and enzymatic criteria of the World Health Organization for acute myocardial infarction (maximal creatine kinase activity, >270 U . I " 1 in men and > 1 7 0 U . l~' in women, or >8% of creatine kinase-MB
1151
, on the basis of their evolution during the 24 h following the admission. These patients developed their acute myocardial infarction 12 ± 10 h after admission. Among them, eight patients (16%) had persistent ST elevation on admission.
Study protocol
For all patients, venous blood samples were obtained at the time of hospital admission, every 4 h thereafter during the first day, and daily for the next 3 days. Total creatine kinase and creatine kinase-MB levels were determined routinely when the blood samples were obtained. The first blood samples obtained at the time of hospital admission were stored at -20 °C and analysed for C-reactive protein and cardiac troponin T at the end of the study. All decisions regarding the care of the patients were made by the physicians in charge, independent of these measurements. . Creatine kinase isoenzyme MB activity was assessed by an immunoinhibition assay (NAC, Merck, Damstadt, Germany). All three protein immunoassays were performed by technicians who were unaware of the clinical data.
Plasma protein assays
Statistical analysis
Data are presented as the mean ± standard deviation, or counts. A Mann-Whitney test was used to compare variables measured from the patients 1231 . P values less than 005 (two-tailed) were considered to indicate statistical significance.
Results
The characteristics of the two groups of patients are listed in Table 1 . There were no clinical differences between the two groups, which differed only in their Eur Heart J, Vol. 18, December 1997 final diagnosis (group 1: unstable angina; group 2: acute myocardial infarction). Age, sex, cardiovascular risk factors, and baseline therapy were similar. There were no significant differences between the two groups in the number of stenotic coronary vessels, or in the pattern of coronary artery disease demonstrated by angiography. Thirty-eight patients (62%) in group 1 and 25 (51%) in group 2 underwent percutaneous transluminal coronary angioplasty; 12 patients (20%) in group 1 and 12 (24%) in group 2 underwent coronary artery bypass grafting; eight patients died in hospital, all in group 2 (/>=0-004). At the time of admission, all patients had normal creatine kinase and creatine kinase-MB serum levels.
Patients with ultimate confirmed diagnosis of unstable angina (Group 1)
The concentration of C-reactive protein at the time of hospitalization was >0-9 mg . dl~ ' in only three (5%) of the 61 patients (1-3; 1-3 and l-4mg.dl~', respectively), with a final diagnosis of unstable angina (Fig. 1) ; the mean value of C-reactive protein was 0-50 ± 0-27mg.dl~'. The mean maximal concentrations of total creatine kinase ( 1 2 4 ± 5 9 I U . r ' [range 38-263; reference range, <170IU for women and <270 IU for men]), and creatine kinase-MB (6-1 ± 0-9% [range, 0-7-6; reference range, <8% of the total creatine kinase if > 170 IU . 1 ' for women and 270IU for men) were normal in all patient samples. The mean concentrations of cardiac troponin T at the time of hospital admission (0-037 ± 007 ug . r ' [range, 0-00-0-37; reference range, 0-00-0-2 ug . 1 ~']) were >0-2ug.l~' in only three patients (5%). There were no clinical or angiographic differences between patients with levels of C-reactive protein >0-9 mg . dl ~ ' and <0-9 mg . dl ~ '.
Patients with ultimate confirmed diagnosis of acute myocardial infarction (Group 2)
The concentration of C-reactive protein at the time of hospital admission was ^O^m g . T appears 4-9 ± 2-8 h after onset of symptoms. There was no difference in C-reactive protein level between the patients with or without a Q wave acute myocardial infarction. Among the 29 patients with elevated C-reactive protein and acute myocardial infarction, 12 (41%) had severe ST elevation (Pardee wave) suggestive of acute ischaemia at the time of hospitalization. Apart from that, we found no other obvious independent evidence of acute myocardial infarction on admission. There were no clinical or angiographic differences between patients with levels of C-reactive protein >0-9mg.dl~' and those with <0-9mg.dl~'. The detailed C-reactive protein levels of both groups are shown in Table 2 .
Discussion
The syndrome of unstable angina nearly always occurs in the setting of atherosclerotic coronary artery disease. Increasingly, it is apparent that functional attributes rather than size alone determines the propensity of atherosclerotic plaque to provoke acute coronary events. Inflammation may contribute to weakening of the atherosclerotic plaque and could play a crucial role in the rupture of the fibrous cap, with subsequent exposure of the lipid-core to circulating blood components, resulting in coronary thrombosis. Previous studies have registered elevated values for acute-phase proteins in patients with unstable angina and acute myocardial 131 . We tested the hypothesis that inflammation within the coronary vessels may reflect the severity of lesions implicated in plaque rupture. The results of our study confirm the observation that, among patients with acute ischaemic heart disease and no biological marker of myocardial necrosis, the plasma concentration of C-reactive protein at the time of admission was significantly higher in patients in whom an acute myocardial infarction was ultimately diagnosed, which makes it an important prognostic marker and a useful tool for clinical management.
Compared to previous studies 124 " 261 , the percentage of patient with elevated cardiac troponin T level and unstable angina in our subjects was low. One explanation for this finding is the small interval between onset of symptoms and hospital admission in our group of patients (5-6 h). Indeed, the level of cardiac enzymes measured during acute coronary events depends directly on the duration of symptoms. It is unlikely that these patients with unstable angina had less acute disease, since their coronary angiographic findings were similar to the patients with acute infarction. Previous history of percutaneous transluminal coronary angioplasty was higher in patients with unstable angina, but symptoms related to restenosis occurred only in two of 15 (13%), which was similar in the group of patients with acute myocardial infarction (15%). Interestingly, the three patients with elevated cardiac troponin T in this unstable angina group corresponded to those with a C-reactive protein >0-9mg.dl~' described above. Finally, the high percentage of patients (41%) with acute myocardial infarction and normal C-reactive protein levels could be due, in out study, to the small interval between onset of symptoms and hospital admission (61 h).
The acute phase of C-reactive protein is a nonspecific phenomenon reflecting cytokine-mediated hepatic production triggered by most forms of inflammation, infection and tissue injury. Our patients were carefully selected to eliminate intercurrent disorders likely to be associated with an acute-phase response, and similar attention to intercurrent processes will be essential for the practical application of our findings.
The elevation of C-reactive protein in acute coronary syndromes is probably related to 'coronary arteritis', and inflammation may then contribute to both vasospasm and thrombosis. Activated vascular wall cells, such as smooth muscle cells, endothelial cells, macrophages, and T lymphocytes, may play a central role because they produce molecules such as interleukin, adhesion molecules, growth factors, procoagulant activity, that alter both vascular reactivity and thrombogenicity' 271 . Elevation of C-reactive protein may therefore reflect the central role of inflammation in the pathophysiology of 'active' coronary artery disease. The beneficial effects of aspirin in unstable angina' 28 " 301 could reflect decreased inflammation in addition to decreased platelet aggregation. In agreement with this hypothesis, Ridker and colleagues demonstrated recently that in apparently healthy men, a high baseline plasma C-reactive protein level predicts the risk of future myocardial infarction (P<0001), and that the use of aspirin was associated with significant reduction in the risk of acute myocardial infarction (/ > <002)' 3 ' 1 .
Early prognostic assessment of myocardial infarction is a key to optimal therapy and management of patients with this common disease, but entirely depends on the availability of rapid and specific diagnostic tests. Thus, the predictive correlation between C-reactive protein levels at the time of admission and the clinical outcomes may have practical clinical importance in the management of patients hospitalized for acute coronary syndromes, and possible cost-saving potential. In actual clinical practice, a C-reactive protein result can be obtained within 60 min. Our results led us to conclude that, in patients with suspected myocardial infarction, the measurement of C-reactive protein at the time of admission could lead to an improvement in the management of myocardial ischaemia, increasing prognostic security, and decreasing delay to appropriate triage and treatment. Large prospective studies are necessary to confirm these findings.
